UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.



FORM 8K



CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



August 19, 2013

Date of Report (Date of earliest event reported)



NMI Health, Inc.

(Exact name of registrant as specified in its charter)





Nevada

000-27421

87-0561647

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)




50 West Liberty Street, Suite 880, Reno, Nevada

89501

(Address of principal executive offices)

(Zip Code)


209-275-9270

Registrant's telephone number, including area code






Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


The Company has accepted the resignations of Michael Marx and Marc Kahn as officers and directors of the Company, and the resignation of Vicky Aksland as a director of the Company, all effective as of August 19, 2013.   Each of the directors resigned for personal reasons not as the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.



SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


DATED: August 20, 2013


NMI Health, Inc. (formerly Nano Mask, Inc.)


By:  /S/ Edward J. Suydam

Edward Suydam, CEO and President